Publications

• NFKB2 haploinsufficiency identified via screening for IFN-2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.
  J Allergy Clin Immunol Volume: 151 Page(s): 926 - 930.e2
  04/01/2023 Authors: Bodansky A; Vazquez SE; Chou J; Novak T; Al-Musa A; Young C; Newhams M; Kucukak S; Zambrano LD; Mitchell A
• COVID-19 Vaccine Reactogenicity and Vaccine Attitudes Among Children and Parents/Guardians After Multisystem Inflammatory Syndrome in Children or COVID-19 Hospitalization: September 2021-May 2022.
  Pediatr Infect Dis J Volume: 42 Page(s): 252 - 259
  03/01/2023 Authors: Yousaf AR; Kunkel A; Abrams JY; Shah AB; Hammett TA; Arnold KE; Beltran YL; Laham FR; Kao CM; Hunstad DA
• Multisystem Inflammatory Syndrome in Adults: Case Finding Through Systematic Review of Electronic Medical Records.
  Clin Infect Dis Volume: 75 Page(s): 1903 - 1911
  11/30/2022 Authors: Melgar M; Haston J; DeCuir J; Cheng Q; Arnold KE; Meng L; Murphy DJ; Overton E; Hollberg J; Tobin-D'Angelo M
• Postdischarge Glucocorticoid Use and Clinical Outcomes of Multisystem Inflammatory Syndrome in Children.
  JAMA Netw Open Volume: 5 Page(s): e2241622
  11/01/2022 Authors: Son MBF; Berbert L; Young C; Dallas J; Newhams M; Chen S; Ardoin SP; Basiaga ML; Canny SP; Crandall H
• Tachyarrhythmias During Hospitalization for COVID-19 or Multisystem Inflammatory Syndrome in Children and Adolescents.
  J Am Heart Assoc Volume: 11 Page(s): e025915
  10/18/2022 Authors: Dionne A; Friedman KG; Young CC; Newhams MM; Kucukak S; Jackson AM; Fitzgerald JC; Smallcomb LS; Heidemann S; McLaughlin GE
• Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
  Lancet Child Adolesc Health Volume: 6 Page(s): 303 - 312
  05/01/2022 Authors: Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP
• Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January-March 2021.
  Antimicrob Steward Healthc Epidemiol Volume: 2 Page(s): e159
  01/01/2022 Authors: Graciaa DS; Verkerke HP; Guarner J; Moldoveanu AM; Cheedarla N; Arthur CM; Maier CL; Neish A; Auld SC; Campbell A
• Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study.
  Clin Infect Dis Volume: 73 Page(s): 2083 - 2092
  12/06/2021 Authors: Brust JCM; Gandhi NR; Wasserman S; Maartens G; Omar SV; Ismail NA; Campbell A; Joseph L; Hahn A; Allana S
• Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.
  JAMA Netw Open Volume: 4 Page(s): e2116420
  06/01/2021 Authors: Payne AB; Gilani Z; Godfred-Cato S; Belay ED; Feldstein LR; Patel MM; Randolph AG; Newhams M; Thomas D; Magleby R
• Schistosoma mansoni Infection Is Associated With a Higher Probability of Tuberculosis Disease in HIV-Infected Adults in Kenya.
  J Acquir Immune Defic Syndr Volume: 86 Page(s): 157 - 163
  02/01/2021 Authors: McLaughlin TA; Nizam A; Hayara FO; Ouma GS; Campbell A; Khayumbi J; Ongalo J; Ouma SG; Shah NS; Altman JD
• Activation-Induced Marker Expression Identifies Mycobacterium tuberculosis-Specific CD4 T Cells in a Cytokine-Independent Manner in HIV-Infected Individuals with Latent Tuberculosis.
  Immunohorizons Volume: 4 Page(s): 573 - 584
  10/02/2020 Authors: Barham MS; Whatney WE; Khayumbi J; Ongalo J; Sasser LE; Campbell A; Franczek M; Kabongo MM; Ouma SG; Hayara FO
• Adults from Kisumu, Kenya have robust T cell responses to Schistosoma mansoni, which are modulated by tuberculosis.
  PLoS Negl Trop Dis Volume: 14 Page(s): e0008764
  10/01/2020 Authors: McLaughlin TA; Khayumbi J; Ongalo J; Matete D; Tonui J; Muchiri B; Sasser LE; Campbell A; Allana S; Ouma SG
• Modeling Missing Cases and Transmission Links in Networks of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
  Am J Epidemiol Volume: 189 Page(s): 735 - 745
  07/01/2020 Authors: Nelson KN; Gandhi NR; Mathema B; Lopman BA; Brust JCM; Auld SC; Ismail N; Omar SV; Brown TS; Allana S
• The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.
  J Acquir Immune Defic Syndr Volume: 83 Page(s): 47 - 55
  01/01/2020 Authors: Smith JP; Gandhi NR; Shah NS; Mlisana K; Moodley P; Johnson BA; Allana S; Campbell A; Nelson KN; Master I
• CD4 T Cells in Mycobacterium tuberculosis and Schistosoma mansoni Co-infected Individuals Maintain Functional TH1 Responses.
  Front Immunol Volume: 11 Page(s): 127
  01/01/2020 Authors: McLaughlin TA; Khayumbi J; Ongalo J; Tonui J; Campbell A; Allana S; Gurrion Ouma S; Odhiambo FH; Gandhi NR; Day CL
• Distinct Human NK Cell Phenotypes and Functional Responses to Mycobacterium tuberculosis in Adults From TB Endemic and Non-endemic Regions.
  Front Cell Infect Microbiol Volume: 10 Page(s): 120
  01/01/2020 Authors: Harris LD; Khayumbi J; Ongalo J; Sasser LE; Tonui J; Campbell A; Odhiambo FH; Ouma SG; Alter G; Gandhi NR
• Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa.
  J Acquir Immune Defic Syndr Volume: 82 Page(s): 124 - 130
  10/01/2019 Authors: Stephens F; Gandhi NR; Brust JCM; Mlisana K; Moodley P; Allana S; Campbell A; Shah S
• Extensively drug-resistant tuberculosis 'hotspots' and sociodemographic associations in Durban, South Africa.
  Int J Tuberc Lung Dis Volume: 23 Page(s): 720 - 727
  06/01/2019 Authors: Peterson ML; Gandhi NR; Clennon J; Nelson KN; Morris N; Ismail N; Allana S; Campbell A; Brust JCM; Auld SC
• HIV Infection Is Associated With Downregulation of BTLA Expression on Mycobacterium tuberculosis-Specific CD4 T Cells in Active Tuberculosis Disease.
  Front Immunol Volume: 10 Page(s): 1983
  01/01/2019 Authors: Barham MS; Abrahams DA; Khayumbi J; Ongalo J; Tonui J; Campbell A; de Kock M; Ouma SG; Odhiambo FH; Hanekom WA
• Extensively drug-resistant tuberculosis inSouth Africa: genomic evidence supporting transmission in communities.
  Eur Respir J Volume: 52
  10/01/2018 Authors: Auld SC; Shah NS; Mathema B; Brown TS; Ismail N; Omar SV; Brust JCM; Nelson KN; Allana S; Campbell A
• Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015.
  Clin Infect Dis Volume: 64 Page(s): 364 - 367
  02/01/2017 Authors: Appiah GD; Chaves SS; Kirley PD; Miller L; Meek J; Anderson E; Oni O; Ryan P; Eckel S; Lynfield R
• Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa.
  PLoS One Volume: 12 Page(s): e0180916
  01/01/2017 Authors: Magee MJ; Sun YV; Brust JCM; Shah NS; Ning Y; Allana S; Campbell A; Hui Q; Mlisana K; Moodley P
• Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa.
  PLoS One Volume: 12 Page(s): e0181797
  01/01/2017 Authors: Kapwata T; Morris N; Campbell A; Mthiyane T; Mpangase P; Nelson KN; Allana S; Brust JCM; Moodley P; Mlisana K